BACKGROUND: While a low estimated glomerular filtration rate (eGFR) confers an increased risk of dying, the mortality associated with high eGFR values has not been ascertained. METHODS: Four variable MDRD-derived eGFR was calculated in a total of 33,386 patients (18,620 F, 14,766 M) aged > or =50 years (median 68 years, IQR 60-76 years) collected by family doctors in 2000. They were then classified according to their eGFR into 30 ml/min/1.73 m(2) bands (<30, 30-59, 60-89, 90-119, 120-150). The subsequent mortality status of each patient was determined at 31st December 2006 and cause of death recorded where available. RESULTS: Applying Cox proportional hazards models (adjusted for age and gender), the hazard ratio (HR) of dying compared to a reference of patients with eGFRs of 60-89 ml/min/1.73m(2) was, as expected, higher in the low eGFR bands (HR 1.37 (95% CI 1.29-1.45) for 30-59; HR 2.60 (2.31-2.93) for <30 ml/min/1.73 m(2), both p < 0.0001). However, it was also greater amongst patients with higher eGFRs (HR 1.29 (1.19-1.41) for 90-119; HR 2.63 (2.16-3.21) for 120-150 ml/min/1.73 m(2), p < 0.0001). Circulatory disease was the main cause of death in patients with low eGFRs and respiratory disease/cancer, in patients with high eGFRs. CONCLUSIONS: As a marker of mortality, both low and high eGFRs are equally predictive of increased mortality in community patients, exhibiting a 'U' shaped curve. Thus, current CKD guidelines which recommend inaction or even the non-reporting of eGFR values greater than 60-90 ml/min/1.73 m(2) may not identify patients who are at an equally high risk of dying as those where intervention is recommended. Copyright 2008 S. Karger AG, Basel.
BACKGROUND: While a low estimated glomerular filtration rate (eGFR) confers an increased risk of dying, the mortality associated with high eGFR values has not been ascertained. METHODS: Four variable MDRD-derived eGFR was calculated in a total of 33,386 patients (18,620 F, 14,766 M) aged > or =50 years (median 68 years, IQR 60-76 years) collected by family doctors in 2000. They were then classified according to their eGFR into 30 ml/min/1.73 m(2) bands (<30, 30-59, 60-89, 90-119, 120-150). The subsequent mortality status of each patient was determined at 31st December 2006 and cause of death recorded where available. RESULTS: Applying Cox proportional hazards models (adjusted for age and gender), the hazard ratio (HR) of dying compared to a reference of patients with eGFRs of 60-89 ml/min/1.73m(2) was, as expected, higher in the low eGFR bands (HR 1.37 (95% CI 1.29-1.45) for 30-59; HR 2.60 (2.31-2.93) for <30 ml/min/1.73 m(2), both p < 0.0001). However, it was also greater amongst patients with higher eGFRs (HR 1.29 (1.19-1.41) for 90-119; HR 2.63 (2.16-3.21) for 120-150 ml/min/1.73 m(2), p < 0.0001). Circulatory disease was the main cause of death in patients with low eGFRs and respiratory disease/cancer, in patients with high eGFRs. CONCLUSIONS: As a marker of mortality, both low and high eGFRs are equally predictive of increased mortality in community patients, exhibiting a 'U' shaped curve. Thus, current CKD guidelines which recommend inaction or even the non-reporting of eGFR values greater than 60-90 ml/min/1.73 m(2) may not identify patients who are at an equally high risk of dying as those where intervention is recommended. Copyright 2008 S. Karger AG, Basel.
Authors: Alberto Montesanto; Francesco De Rango; Maurizio Berardelli; Vincenzo Mari; Fabrizia Lattanzio; Giuseppe Passarino; Andrea Corsonello Journal: Age (Dordr) Date: 2014-03-25
Authors: David G Warnock; Paul Muntner; Peter A McCullough; Xiao Zhang; Leslie A McClure; Neil Zakai; Mary Cushman; Britt B Newsome; Reshma Kewalramani; Michael W Steffes; George Howard; William M McClellan Journal: Am J Kidney Dis Date: 2010-08-08 Impact factor: 8.860
Authors: María M Adeva-Andany; Carlos Fernández-Fernández; Lucía Adeva-Contreras; Natalia Carneiro-Freire; Alberto Domínguez-Montero; David Mouriño-Bayolo Journal: Curr Cardiol Rev Date: 2021
Authors: Nawar M Shara; Hong Wang; Mihriye Mete; Yaman Rai Al-Balha; Nameer Azalddin; Elisa T Lee; Nora Franceschini; Stacey E Jolly; Barbara V Howard; Jason G Umans Journal: Am J Kidney Dis Date: 2012-07-25 Impact factor: 8.860
Authors: David H Smith; Micah L Thorp; Jerry H Gurwitz; David D McManus; Robert J Goldberg; Larry A Allen; Grace Hsu; Sue Hee Sung; David J Magid; Alan S Go Journal: Circ Cardiovasc Qual Outcomes Date: 2013-05-17
Authors: T W Felton; W W Hope; B M Lomaestro; J M Butterfield; A L Kwa; G L Drusano; T P Lodise Journal: Antimicrob Agents Chemother Date: 2012-05-14 Impact factor: 5.191
Authors: Fowzia Ibrahim; Lisa Hamzah; Rachael Jones; Dorothea Nitsch; Caroline Sabin; Frank A Post Journal: Am J Kidney Dis Date: 2012-04-21 Impact factor: 8.860